Cantor Fitzgerald, L. P. Rezolute, Inc. Put Options Transaction History
Cantor Fitzgerald, L. P.
- $4.65 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RZLT
# of Institutions
82Shares Held
39.7MCall Options Held
402KPut Options Held
19.4K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$50 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$10.5 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.11MShares$9.36 Million1.66% of portfolio
-
Marshall Wace, LLP London, X01.85MShares$8.17 Million0.01% of portfolio
-
Blackstone Inc New York, NY1.74MShares$7.73 Million0.02% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $172M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...